US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN): Analyst Consensus Suggests a 53% Upside for a Biotech Innovator

BioMarin Pharmaceutical Inc. (BMRN), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline and strategic focus on therapies for rare diseases. With a..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a High-Growth Biotech with 15% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its innovative approach to central nervous system (CNS) disorders. With a market capitalization of $12.07 billion, this..

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its 11.96% Upside Potential

Biogen Inc. (BIIB), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, presents a compelling case for investors with its robust portfolio and strategic collaborations. With..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: High Buy Ratings and Promising Growth Prospects

For investors keeping an eye on the healthcare sector, Lantheus Holdings, Inc. (NASDAQ: LNTH) presents a compelling case with its strong market positioning in the specialty drug manufacturing industry. Notably,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 21% Potential Upside Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands as a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $15.92 billion,..

Oscar Health, Inc. (OSCR) Stock Analysis: Evaluating the Healthcare Tech Innovator’s Growth Trajectory

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology landscape, has been attracting significant attention from investors, thanks to its impressive revenue growth and innovative approach to..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 8% Potential Upside Amidst Mixed Performance Metrics

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, presents a mixed bag of metrics that investors should carefully consider...

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Powerhouse with 31.90% Revenue Growth and Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a dynamic player within the biotechnology sector, carving its niche with groundbreaking genetic medicines aimed at treating diseases with significant unmet medical needs. With..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 12.47% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a heavyweight in the diagnostics and research industry with a market capitalization of $23.86 billion, is a company that continues to capture the attention of..

Bruker Corporation (BRKR) Stock Analysis: Navigating a Challenging Valuation with Promising Growth in Medical Devices

Bruker Corporation (NASDAQ: BRKR) is a prominent name in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.96 billion, Bruker is a well-established player,..

Cencora, Inc. (COR) Stock Analysis: Evaluating a 32% Upside Potential in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, particularly in medical distribution, has piqued investor interest with its recent name change from AmerisourceBergen Corporation. With a robust..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 13.89% Potential Upside

For investors eyeing the healthcare sector, Henry Schein, Inc. (NASDAQ: HSIC) presents intriguing opportunities. With a market capitalization of $8.72 billion, this U.S.-based medical distribution giant operates across diverse segments,..

The Cigna Group (CI) Stock Analysis: Exploring a Solid 23.11% Potential Upside

As the healthcare sector continues to attract investor interest, The Cigna Group (NYSE: CI) emerges as a compelling option with promising growth potential. With a robust market cap of $73.38..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 30% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the Health Information Services industry, is catching the eye of investors with its significant potential upside. Trading at $87.99, the company shows..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 72% Potential Upside in Healthcare Software

For investors seeking opportunities in the healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) presents an intriguing proposition. This Lehi, Utah-based company specializes in developing a cloud-based software platform aimed at..

Stevanato Group S.p.A. (STVN) Stock Analysis: An Under-the-Radar Healthcare Gem with 33% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) stands out as a significant player in the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Piombino Dese, Italy, the company..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 40% Potential Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH), a notable player in the healthcare sector, is attracting attention from investors due to its substantial potential upside. The company, with a market capitalization..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Growth Potential with a 14% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a prominent player in the healthcare sector, specializes in medical instruments and supplies, primarily focusing on eye health. With a market capitalization of $5.58..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 61.62% Potential Upside with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is garnering significant attention from investors. With a market capitalization of $4.37..

Illumina, Inc. (ILMN) Stock Analysis: Understanding the Growth Potential Amidst a Robust Market Cap

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the diagnostics and research industry, is captivating investor attention with its significant market cap of $24.66 billion. The company, headquartered in San..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds